SICK’s gas analysis and flow measurement technology is now an integral part of Endress+Hauser’s comprehensive instrumentation portfolio. The collaboration is designed to offer customers in the process industry enhanced support in increasing plant efficiency, protecting the environment and reducing carbon footprint.
Expanded offering and expertise
As a result of the strategic partnership, around 800 sales and service employees from SICK will transfer to Endress+Hauser across 42 countries. The collaboration in process automation will allow customers to access a broader range of products from a single source and benefit from enhanced expertise in gas measurement technology. With its global sales network, Endress+Hauser will access new customers, reach additional industries and tap into further application areas.
Joint venture for development and manufacturing
The production and further development of the gas analyzers and flowmeters were brought together under the umbrella of Endress+Hauser SICK GmbH+Co. KG. SICK and Endress+Hauser will each hold 50 percent of the joint venture as of 1 March 2025. The company employs around 730 people at several German sites and will collaborate closely with Endress+Hauser’s product centers to drive product innovation and meet evolving market demands.
Seamless business transition
Hundreds of employees from both companies have been preparing for the smooth transition of the business in recent months. Now the gas measurement sales and service teams at Endress+Hauser are ready to provide support, and endress.com reflects the expanded range of products, solutions and services. Since 1 January 2025, Endress+Hauser has been exclusively marketing SICK’s gas analysis and flow measurement technology worldwide.
In China, the transition will not take place until 1 March 2025 for technical reasons. In Türkiye and Saudi Arabia, sales and service will be transferred to Endress+Hauser in the first quarter.
“This partnership is a perfect match,” said Dr. Peter Selders, CEO of the Endress+Hauser Group. “It creates new opportunities for growth and development, particularly in the sustainable transformation of the process industry. By joining forces, we offer added value to our customers. Our combined efforts will make us faster and ultimately more successful than if we acted alone. In this case, one and one equals more than two.”
Opportunities for growth and development
“We are pleased that the strategic partnership for process automation is now starting. Together, we can better support customers worldwide and guide them into a sustainable future with leading technological solutions. We are convinced that the transformation of the process industry offers enormous opportunities for growth and development, which we will optimally leverage as strong partners,” said Dr. Mats Gökstorp, chairman of the executive board of SICK AG.
Factory & logistics automation not part of the partnership
With 60 subsidiaries and shareholdings as well as numerous agencies, SICK maintains a presence around the globe. The company has over 12,000 employees worldwide and generated consolidated sales of 2.3 billion euros in the 2023 financial year. The core business of factory and logistics automation, which accounts for more than 80 percent of sales, will not be affected by this partnership.